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Introduction
Recycling is a well-known feature of intracellular protein
trafficking, occurring during endocytosis (Brown et al.
1983; Podbilewicz and Mellman, 1990; Steinman et al.
1983). Recycling is defined as the inter-organelle move-
ment of a molecule followed by its return to the original
site, without intervening metabolic processing. More specif-
ically, it occurs for instance in the endocytic pathway of a
receptor-ligand complex, involving internalization and
return of the unmodifiedand intactreceptor to the plasma
membrane. 
The potential importance of this process in the con-
comitant intracellular flow of lipids is now also emerging.
Several sphingolipids have been shown to reappear at the
plasma membrane by a recycling mechanism, after exoge-
nous membrane insertion and subsequent internalization by
endocytosis (Kok et al. 1989; Koval and Pagano, 1989,
1990). In this respect glycolipids may be of special inter-
est, since most species belonging to this class of lipids are
thought to reside mainly in the outer leaflet of the plasma
membrane, in accordance with their functions in cell sur-
face recognition phenomena (Curatalo, 1987; Hakomori,
1981; Hoekstra and Düzgünes, 1989). Recently we have
presented direct evidence that the neutral glycolipid gluco-
sylceramide is sorted during inbound cellular trafficking,
thus voiding degradation in the lysosomal compartment
(Kok et al. 1991). By inference, similar conclusions can be
drawn from work described by others (Trinchera et al. 1990;
Usuki et al. 1988), in which the same class of lipids was
studied. 
Internalization and recycling pathways can be character-
ized by making use of ligand-receptor complexes with a
well-known intracellular cycle. The iron transporter trans-
ferrin (Tf) is rapidly internalized to early endosomes, an
organelle which appears to play a pivotal role in intracel-
lular sorting (Stein and Sussman, 1986; Stoorvogel et al.
1987). After iron-discharge the apo-transferrin, still bound
to its receptor, recycles back to the plasma membrane from
the e early endosomes. A minor fraction recycles via the
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Recycling pathways of the sphingolipid glucosylce-
ramide were studied by employing a fluorescent analog
of glucosylceramide, 6-[N-(7-nitro-2,1,3-benzoxadiazol-
4-yl)amino]hexanoylglucosylsphingosine (C6-NBD-glu-
cosylceramide). Direct recycling of the glycolipid from
early endosomes to the plasma membrane occurs, as
could be shown after treating the cells with the micro-
tubule-disrupting agent nocodazole, which causes inhi-
bition of the glycolipid’s trafficking from peripheral
early endosomes to centrally located late endosomes.
When the microtubuli are intact, at least part of the
glucosylceramide is transported from early to late endo-
somes together with ricin. Interestingly, also N-( is-
samine rhodamine B sulfonyl)phosphatidylethanol-
amine (N-Rh-PE), a membrane marker of the
fl uid-phase endocytic pathway, is transported to this
endosomal compartment. However, in contrast to both
ricin and N-Rh-PE, the glucosylceramide can escape
from this organelle and recycle to the plasma mem-
brane. Monensin and brefeldin A have little effect on
this recycling pathway, which would exclude extensive
involvement of early Golgi compartments in recycling.
Hence, the small fraction of the glycolipid that colocal-
izes with transferrin (Tf) in the Golgi area might
directly recycle via the trans-Golgi network. When the
intracellular pH was lowered to 5.5, recycling was dras-
tically reduced, in accordance with the impeding effect
of low intracellular pH on vesicular transportduring
endocytosis and in the biosynthetic pathway.
Our results thus demonstrate the existence of at least
two recycling pathways for glucosylceramide and indi-
cate the relevance of early endosomesin recycling of
both proteins andlipids.
Key words: early endosome, fluorescence microscopy, glycolipid,
Golgi, recycling. 
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Golgi region (Stein and Sussman, 1986). Several other lig-
ands, like ricin, move further down the endocytic pathway
towards the lysosomal system.
In the present study it is shown that a ßuorescent analog
of the glycolipid glucosylceramide can - like transferrin -
directly recycle from early endosomes to the plasma mem-
brane after initial uptake into the cell along the pathway of
receptor-mediated endocytosis. From these early endo-
somes a fraction of the glycolipid - but not transferrin - can
be transported to late endosomes along an identical route
to that for ricin, a marker for the endocytic pathway towards
the endo-lysosomal system. However, in contrast to ricin,
glucosylceramide is only transiently present in this
organelle as it can escape from this compartment and sub-
sequently return to the plasma membrane.
Materials and methods
Materials
1-b-D-glucosylsphingosine, D-sphingosine, iron-free human trans-
ferrin (Tf), monensin, nocodazole, brefeldin A (BFA) and cytocha-
lasin D were purchased from Sigma. 6-[N-(7-nitro-2,1,3-ben-
zoxadiazol-4-yl)amino]hexanoic acid (C6-NBD), lissamine
rhodamine B sulfonyl chloride (LR), 10% (w/w) on celite, N-(lis-
samine rhodamine B sulfonyl)phosphatidylethanolamine (N-Rh-
PE), propidium iodide and bodipy-phallacidin were from Molec-
ular Probes. Anti-a-tubulin antibody was from Amersham.
Anti-mouse antibodies (FITC-conjugated) were from Dakopatts
(Denmark). Ricin RCA60 was a gift from Dr. E. Nicolas, Uni-
versité René Descartes, Department of Biochemistry, Paris.
Synthesis of C6-NBD-labeled sphingolipids
C6-NBD-glucosylceramide and C6-NBD-ceramide were synthe-
sized from C6-NBD and 1-b-D-glucosylsphingosine and D-sphin
gosine, respectively, as described (Kishimoto, 1975). The C6-NBD
lipids were quantitated spectrophotometrically in a fluorometer
(Perkin-Elmer MPF-43) with an excitation wavelength of 465 nm
and an emission wavelength of 530 nm, by reference to a known
amount of C6-NBD-phosphatidylcholine.
Protein labeling
Saturation of Tf with iron was carried out by the procedure of
Van Renswoude et al. (1982). Diferric Tf and ricin were conju-
gated with LR as described elsewhere (Kok et al. 1989).
Cell culture and membrane insertion of fluorescent lipids
Monolayer cultures of baby hamster kidney cells (BHK-21) were
grown in Glasgow minimum essential medium, supplemented with
5% (v/v) fetal calf serum and 10% (v/v) tryptose phosphate broth
in a water-saturated atmosphere of 5% CO2 (95% air). Experi-
ments were carried out 48-72 h after passage. C6-NBD-lipid inser-
tion was carried out at 2˚C. Prior to labeling, the cells were cooled
to 2˚C (30 min). Two procedures were employed to insert the flu-
orescent lipid analog into the plasma membrane of the cells.
(i) The cells were incubated with donor membranes, consisting of
C6-NBD-lipid-containing liposomes. To this end, small unilamel-
lar vesicles (190 nmol of dioleoylphosphatidylcholine and 10 nmol
of C6-NBD-lipid in 1 ml of Hanks’ solution) were freshly pre-
pared for each experiment by probe sonication for 10-15 min on
ice and under nitrogen. (ii) Alternatively, an appropriate amount
of C6-NBD-lipid, stored in chloroform/methanol (2:1, v/v), was
dried under nitrogen and subsequently solubilized in absolute
ethanol. A sample of the ethanolic solution (0.5%, final concen-
tration) was injected into Hanks’ solution (pH 7.4) under vigor-
ous vortex mixing. This solution was then added to the cells. The
latter method was also used for the insertion of N-Rh-PE (Kok et
al. 1990).
Lipid and protein internalization
Labeling of the cells with LR-Tf (0.2 mg/ml) or LR-ricin (15
mg/ml) was carried out for 30 min at 2˚C, whereafter the unbound
Tf or ricin was removed by washing the cells with ice-cold Hanks’
solution. To initiate the internalization of the membrane-inserted
lipid and the membrane-bound protein ligand, the cells were
warmed to 37˚C by adding warm Hanks’ solution. At various
times, the buffer was removed and replaced by ice-cold (2˚C)
Hanks’ solution.
Back-exchange of membrane-inserted lipid analogs
A back-exchange procedure was carried out by incubating the cells
for 30 min at 2˚C with 5% (w/v) bovine serum albumin (BSA) in
Hanks’ solution, followed by extensive washings with Hanks’
solution and another incubation with 5% BSA in Hanks’ solution
(30 min at 2˚C). Fluorescence was measured after lipid extraction
of the BSA solution and the cells, to determine the back-
exchanged fraction, and to calculate the percentage of internal-
ization or recycling.
Lipid extraction, analysis and quantification
Lipids were extracted by the procedure of Bligh and Dyer (1959)
and analyzed by thin-layer chromatography (TLC) on silica gel
60 HPTLC plates (Merck), using CHCl3/CH3OH/20%(w/v)-
NH4OH (70:30:5, by vol.) as the running solvent system. For
quantification, individual spots were scraped off the plates and
after addition of 3 ml of a 1% (v/v) Triton X-100 solution, shaken
vigorously for 1 h at 37˚C. After spinning down the silica parti-
cles, the supernatant was measured by reference to a standard
curve, as described above. Corrections were made for differences
in efficiency of removal of different lipids from the silica. 
Recycling
Microscopic visualization of lipid recycling and chemical analy-
sis of internalized and recycled lipids were done as follows. The
cells were labeled at 2˚C with C6-NBD-glycolipid. Internalization
was then triggered by warming the cells to 37˚C. After 30 min at
37˚C, the cells were cooled and a back-exchange procedure was
carried out at 2˚C, as described above, to remove all residual
plasma membrane-incorporated NBD-lipid. After this back-
exchange, the cells were again warmed to 37˚C for various times,
either in Hanks’ buffer or in the same buffer supplemented with
5% BSA (w/v). Finally, after cooling, a second back-exchange
was carried out, if appropriate. For analysis of the chemical nature
of th  cell-associated and back-exchanged fluorescent molecules,
each relevant fraction was subjected to a lipid extraction.
The effects of monensin, BFA, metabolic inhibitors and cytosol
acidification on recycling were studied as follows. In the case of
BFA treatment, the cells were preincubated with BFA (2 mg/ml)
in Hanks’ solution for 30 min at 37˚C and all subsequent incu-
bations at 37˚C were carried out in the presence of BFA. Cells
w re labeled with 4 mM C6-NBD-glucosylceramide at 2˚C. The
NBD- lycolipid was then allowed to internalize, as accomplished
by raising the temperature to 37˚C. After an appropriate time inter-
val, the remaining pool of plasma membrane associated lipid was
removed by a back-exchange procedure. Subsequently, the cells
were incubated at 2˚C for 30 min with 10 mM monensin, 5 mM
sodium azide/50 mM 2-deoxyglucose or, to acidify the cytosol, in
a 5 mM nigericin-containing isotonic KCl buffer solution (140 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, 0.5 mM KH2PO4, 20 mM Hepes,
pH 5.5). (Owing to the ability of nigericin to exchange K1 for
J. W. Kok and others
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H1, the pH of the cytosol will equilibrate with that of the sur-
rounding medium when the concentration of K1 is the same at
either side of the membrane (Frelin et al. 1988; Grinstein et al.
1984).) Thereafter the cells were warmed to 37˚C for 45 min in
the presence of the drugs. Finally, a second back-exchange pro-
cedure was performed to determine the amount of recycled lipid.
The effect of monensin or BFA on transport from the Golgi appa-
ratus to the plasma membrane was established as follows: if appro-
priate, the cells were pre-incubated with BFA (2 m g/ml) for 30
min at 37˚C. The cells were labeled at 2˚C for 30 min with 4 m M
C6-NBD-ceramide. This was followed by an incubation with 10
m M monensin at 2˚C for 30 min if appropriate. Subsequently the
cells were warmed to 37˚C for 45 min in the presence of either
drug.
In the case of both glucosylceramide recycling and transport of
newly synthesized glucosylceramide the transport to the plasma
membrane in drug-treated cells relative to that in control cells is
expressed using the equation:
PMT/(PMT + IT)R=———————
PMC/(PMC + IC)
(PM, plasma membrane glucosylceramide pool; I, intracellular
glucosylceramide pool; T, treated cells; C,control cells), yielding
a value of zero in the case of complete inhibition by the drug and
unity if the drug has no effect. 
Cytoskeletal disruption
To study the involvement of the cytoskeleton in the process of
internalization and recycling of NBD-glucosylceramide, cells were
preincubated with either nocodazole (10 m g/ml) for 90 min at 37˚C
or cytochalasin D (10 m g/ml) for 15 min at 37˚C to disrupt micro-
tubuli or actin filaments, respectively. All subsequent incubations
were carried out in the presence of either drug. To determine the
kinetics of breakdown and recovery (after removal of the drug by
extensive washing) of these cytoskeletal elements, indirect
immunofluorescence microscopy was employed. The cells were
fi xed for 10 min in 4% formaldehyde in a cytoskeleton-stabiliz-
ing buffer (100 mM Pipes, 5 mM EGTA, 2 mM MgCl2, pH 6.8)
containing 0.1% Triton X-100. After washing the specimen with
PBS, the cells were post-fixed for 5 min in 220˚C methanol or
ethanol for tubulin or actin labeling, respectively. After repeated
PBS washings the cells were incubated with 10% fetal calf serum
to saturate non-specific protein binding sites. In the case of tubu-
lin staining, the cells were incubated with anti-a - ubulin antibod-
ies at room temperature for 30 min and, after extensive washing
with PBS, with FITC-conjugated anti-mouse antibodies for 30
min. For actin staining, bodipy-conjugated phallacidin was used.
Microscopy
Cells were grown on glass coverslips in 35-mm Petri dishes. Prior
to experiments, the cells were cooled (30 min) and washed sev-
eral times with ice-cold Hanks’ solution. For colabeling studies,
the cells were first labeled with the C6-NBD-lipid for 30 min at
2˚C followed by washing with Hanks’ solution and subsequent
labeling with LR-Tf (0.2 mg/ml), LR-ricin (15 m g/ml) or N-Rh-
PE (1 m M). Internalization was initiated by adding warm (37˚C)
Hanks’ solution, and after various times the trafficking processes
were stopped by replacing warm buffer with ice-cold buffer.
Thereafter a back-exchange was carried out at 2˚C, followed, in
the case of ricin labeling, by a 0.1 M lactose wash (30 min at
2˚C) to remove cell-surface-bound ricin. To examine the effect of
BFA on glucosylceramide trafficking, cells were preincubated
with BFA (2 m g/ml) for 30 min at 37˚C, followed by labeling with
C6-NBD-glucosylceramide at 2˚C and subsequent internalization
for 30 min at 37˚C in the presence of the drug. The BFA effect
on the Golgi apparatus was assessed by first labeling the Golgi
apparatus with C6-NBD-ceramide during 30 min at 37˚C, followed
by another 30 min incubation at 37˚C in the presence of BFA.
Cell vi bility was checked in all microscopic experiments by
addition of propidium iodide (10 m g/ml) to the incubation medium.
This dye is excluded from viable cells but stains nuclei of dis-
rupted cells. 
In some experiments the cells were fixed for 30 min at room
temperature with 2% (v/v) formaldehyde in buffer containing 20
mM sodium phosphate (pH 7.4), 100 mM lysine, 60 mM sucrose
and 100 mM sodium periodate, post-fixed sequentially with 4%
formaldehyde and with 6% formaldehyde, both in the same buffer,
for 5 and 10 min, respectively. 
Fluor scence microscopy was performed with a Leitz Ortho-
plan or a Zeiss Axiovert 405 M microscope, using filter sets, as
desc ibed elsewhere (Kok et al. 1990). Photomicrographs were
taken at 10-30 s exposition times using Kodak T-max P3200 film
that was processed at 3200 up to 12,800 ASA.
Miscellaneous procedures
Protein was determined by the Lowry procedure, modified as
described by Peterson (1977). Bovine serum albumin was used as
a standard. Phospholipid phosphorus was determined after per-
chloric acid destruction according to Böttcher et al. (1961).
Results and discussion
Internalization and recycling kinetics
C6-NBD-glucosylceramide can be readily inserted into the
outer leaflet of the plasma membrane of BHK cells at 2˚C.
When the cells are subsequently warmed to 37˚C, the gly-
colipid is internalized via the pathway of receptor-mediated
endocytosis (Kok et al. 1989). Fig. 1 shows the kinetics by
which the lipid is removed from the plasma membrane and
gains intracellular access. Initial internalization occurs at a
relatively rapid rate as after only 2 min, ~25% of the max-
imal internalized amount (under steady-state conditions) is
found intracellularly. At steady-state conditions ~20% of
the total cell-associated lipid fraction resides inside the cell,
which implies that a relatively high percentage of the total
lipid pool remains associated with the plasma membrane,
either because of its persistent presence in the plasma mem-
brane as such or by recycling to the plasma membrane after
initial uptake into the cell.
Recycling of internalized glycolipid to the plasma mem-
brane, i.e. the return ofi tact molecules that have not been
modified metabolically, was measured next. The cells were
labeled with the glycolipid and internalization was allowed
to proceed for 30 min. After 30 min at 37˚C a steady state
is reached in the distribution of the intracellular labeling
patt rn (Kok et al. 1989), indicating that all possible
organelles to be reached by the glycolipid are labeled at
that time point. Subsequently a back-exchange procedure is
carried out to remove the residual pool of plasma mem-
brane-associated NBD-glycolipid. The overall kinetics of
recycling from intracellular organelles can now be estab-
lished by determining the time of reappearance of intact C6-
NBD-glucosylceramide at the plasma membrane occurring
upon further incubating the cells at 37˚C for various time
intervals (Fig. 2a). The early kinetics of recycling are
extremely fast as approx. 20% of the total fraction involved
in recycling during a period of 60 min can be recovered
1142
during the first minute. After about 1 h, recycling seems to
level off, yielding a ratio of plasma membrane fraction to
internal fraction which is comparable to that reached during
internalization (Fig. 1). However, once recycled to the
plasma membrane, NBD-glycolipid molecules may well be
subject to another internalization cycle, thus contributing to
the kinetics monitored during a 60 min recycling experi-
ment. To investigate this issue, an alternative recycling
experiment was performed in which the cells were incu-
bated in Hanks’ solution containing 5% (w/v) BSA during
recycling. The presence of BSA as NBD-glycolipid accep-
tor will ensure that any C6-NBD-glycolipid molecule that
recycles to the plasma membrane will be effectively
removed prior to its ability to engage in a second round of
internalization. As shown in Fig. 2b, the kinetics of recy-
cling are indeed different under these conditions. The dis-
appearance of the glycolipid from intracellular organelles
is more extensive and after 60 min only 5% has not yet
returned to the cell surface. By contrast, in the absence of
BSA, approximately 30% of the lipid fraction is located
intracellularly. From the kinetic curve obtained in the pres-
ence of BSA, which thus represents true recycling without
interference of repeated internalization, a half-life of 12.5
min for C6-NBD-glucosylceramide can be calculated.
From the distinction in the kinetics of recycling as
revealed by a comparison of the rates in the absence and
presence of BSA (Fig. 2b), it is clear that after their recy-
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Fig. 1.Kinetics of internalization of C6-NBD-glucosylceramide in
BHK cells. Cells were labeled with 4 m M C6-NBD-
glucosylceramide and allowed to internalize the lipid at 37˚C for
various time intervals. After a subsequent back-exchange
procedure NBD-lipid was quantified in the cell fraction (s- s,
intracellular), the back-exchange fraction (d- d, plasma
membrane) and the 37˚C incubation medium (- m, expelled in
medium), as described in Materials and methods, and expressed as
the percentage of total NBD-lipid in all three fractions. The 100%
value corresponds to approximately 55 pmol/106cells. Data points
are the means of duplicate measurements.
Fig. 2. Kinetics of recycling of C6-NBD-glucosylceramide from
intracellular organelles to the plasma membrane of BHK cells.
Cells were labeled with 4 m M C6-NBD-glucosylceramide and
allowed to internalize the lipid for 30 min at 37˚C. Thereafter a
back-exchange procedure was carried out to remove all residual
plasma membrane NBD-lipid. Subsequently the cells were
warmed again to 37˚C for various time intervals, followed by a
second back-exchange procedure. The latter removes the NBD-
lipid that has recycled from intracellular organelles to the plasma
membrane. NBD-lipid was quantified, as described in Materials
and methods, in the cell fraction (s- s, intracellular), the second
back- xchange fraction (d- d, plasma membrane: recycled
fraction) and the 37˚C incubation medium (m- m), expelled in
medium), and expressed as the percentage of total NBD-lipid in
all three fractions (a). The 100% value corresponds to
approximately 11 pmol/106 cells. In (b) the percentage of total
NBD-lipid, which is present intracellularly is depicted, both in the
absence (s- s) and presence (d- d) of BSA in the 37˚C medium
(5% w/v) as a NBD-lipid scavenger. Note that curve (s- s) is
identical to curve (s- s) of (a). Data points are the means (±
s.e.m.) of triplicate measurements.
a
b
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cling to the plasma membrane, glycolipid molecules may
re-enter the internalization pathway. This eventually leads
to a steady state in which 70-80% of the glycolipid resides
in the plasma membrane while the remaining fraction is
located intracellularly. This distribution of the NBD-gly-
colipid is in reasonable agreement with measurements of
the surface area of the plasma membrane versus the endo-
somal apparatus (Griffiths et al. 1989), indicating that under
steady-state conditions the glycolipid is distributed approx-
imately according to membrane surface area.
Consistent with previous observations (Kok et al. 1989),
the recycled fraction consists exclusively of intact C6-NBD-
glucosylceramide, as revealed by lipid extraction and thin
layer chromatography (not shown). Thus, after recycling the
only lipid the plasma membrane contains is this NBD-
labeled (sphingo)lipid. In this context, it should be noted
that metabolic experiments employing C6-NBD-ceramide as
a precursor for sphingolipid synthesis have shown that both
C6-NBD-glucosylceramideand C6-NBD-sphingomyelin
are formed and transported to the plasma membrane, in a
ratio of glucosylceramide to sphingomyelin of 0.85 (unpub-
lished results). Thus substantial degradation of glucosyl-
ceramide to ceramide should have resulted in a significant
synthesis of sphingomyelin and its subsequent transport to
the plasma membrane. Since during the time course of the
recycling experiments no C6-NBD-sphingomyelin is found,
we conclude that all C6-NBD-glucosylceramide present in
the plasma membrane stems from genuine recycling of
intact molecules, i.e. molecules that have not been
processed metabolically. Finally, it is relevant to note that
the recycling experiment (Fig. 2b) in the presence of BSA
reveals that essentially the entire pool of internalized lipid
can be recycled within a time interval of about one hour.
Hence, recycling of glucosylceramide is not restricted to a
particular fraction of the intracellular pool.
Internalization and recycling pathways: the early
endosomal level
C6-NBD-glucosylceramide is internalized along the path-
way of receptor-mediated endocytosis. Two minutes after
triggering internalization, the lipid analog is located in early
endosomes, as inferred from its colocalization with LR-Tf:
transferrin is by definition a marker for early endosomes
after 2 min of uptake (Eskelinen et al. 1991; Chiechanover
et al. 1983; Dautry-Varsat et al. 1983; Van Renswoude et
al. 1982). When colabeling experiments were performed
with LR-ricin, this marker was similarly found to colocal-
ize with the NBD-glycolipid at the early endosomal level,
2 min after initiating internalization (cf. Fig. 4). However,
the early endosomes were not labeled by N-Rh-PE (cf. Fig.
5), a membrane traffic marker of the fluid-phase endocytic
pathway (Kok et al. 1990). 
As shown in Fig. 3, trafficking from early to late endo-
somes can be reversibly blocked by incubating the cells
with nocodazole, which disrupts the microtubular system.
(To ascertain the effectiveness of disruption and its
reversibility, the kinetics of breakdown and recovery were
monitored microscopically by indirect immunofluorescent
staining of a -tubulin; not shown.) The compartment in
which C6-NBD-glucosylceramide accumulates during a 30
min incubation at 37˚C after nocodazole treatment is the
same compartment as that labeled by LR-Tf, when this
igand i  allowed to internalize for only 2 min at 37˚C (Fig.
3). This indicates that the block of glucosylceramide traf-
fi cki g is indeed at the level of the early endosomes, which
by definition are labeled by transferrin after 2 min of uptake.
Indeed, in support of our claim is the observation that trans-
fer of VSV G protein from early to late endosomes in BHK
c lls is also blocked in the presence of nocodazol (Gruen-
berg et al. 1989). After a 30 min accumulation of C6-NBD-
glucosylceramide in early endosomes, a back-exchange was
performed to remove residual plasma membrane NBD-gly-
colipid. When the incubation of the cells is subsequently
continued at 37˚C, still in the presence of nocodazole, the
g ycolipid recycles from early endosomes to the plasma
membrane, as shown in Fig. 3. It thus follows that micro-
tubuli are not required for recycling of the glycolipid via
early endosomes, consistent with observations on the recy-
cling f Tf (Sakai et al. 1991); whereas delivery of endo-
cytosed Tf to the cytocenter is blocked, recycling to the
plasma membrane proceeds normally. 
Internalization and recycling pathways: the late endosomal
level
Under n rmal conditions, i.e. when the microtubular system
is unperturbed, C6-NBD-glucosylceramide not only recy-
cles from early (peripheral) endosomes to the plasma mem-
brane, but part of the lipid analog is transported further into
the cell, towards the cell center. After 5 to 15 min of inter-
nalization large spherical vesicles become labeled (Kok et
al. 1989), which are localized more centrally compared to
early endosomes. In addition, some labeling can also be
found in the Golgi area, a distinct juxtanuclear area in BHK
c lls. As shown in Fig 4, colocalization of the glycolipid
with LR-Tf is, after longer times of incubation (15 min),
restricted to this Golgi area, since transferrin is not found
in the large sperical vesicles. In order to identify the latter
vesicles, colabeling experiments were performed with other
endocytic markers. As shown in Fig. 4, colabeling with LR-
ricin revealed that C6-NBD-glucosylceramide is transported
togeth r with this protein ligand, not only through early
e dosomes, but also to the large spherical vesicles, where
both probes colocalize up to incubation times of 30 min.
Only after 60 min at 37˚C, did the labeling pattern of LR-
ricin d viate from that of the NBD-glycolipid. At that time
LR-ricin was present in very large spherical vesicles, most
likely lysosomes, since N-Rh-PE also accumulates in large
spherical lysosomes after 60 min of uptake, as revealed by
density gradient analyses (Kok et al. 1990). In this com-
partment C6-NBD-glucosylceramide was never found (Fig.
4). 
After 15 min of internalization, C6-NBD-glucosyl-
ceramide was also observed to colocalize with N-Rh-PE in
the large spherical vesicles, as shown in Fig. 5. Interest-
ingly, in contrast to N-Rh-PE, C6-NBD-glucosylceramide
could be chased out of this compartment. This was accom-
plished by incubating the cells further at 37˚C for 5 to 10
min, after first having removed the plasma membrane pool
by a back-exchange (Fig. 5). Similar observations were
made in the case of the colocalization studies with LR-ricin.
Whereas the NBD-glycolipid could be chased from this
organelle, the ricin could not (not shown). Apparently the
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Fig. 3.Reversible inhibition of transport of C6-NBD-glucosylceramide to late endosomes by nocodazole and direct recycling from early
endosomes to the plasma membrane. In all samples the cells were pretreated as indicated and subsequently labeled with 4 µM C6-NBD-
glucosylceramide, followed by incubation at 37˚C for 30 min and finally a back-exchange procedure. (a) Control cells (i.e. not treated
with nocodazole) were preincubated for 90 min in Hanks’ solution. Fluorescent glucosylceramide accumulates in a central region.
(c) Cells were preincubated for 90 min in Hanks’ solution containing 10 m g/ml nocodazole to disrupt microtubuli. Fluorescent
glucosylceramide does not move from a peripheral location in the cell to the central region as in a. (d) The same sample as in c was
labeled with LR-Tf (0.2 mg/ml), which was allowed to internalize for only 2 min at 37˚C. By definition the transferrin reaches the early
endosomes. Note that Tf (d) colocalizes with glucosylceramide (c) which has been internalized for 30 min. Thus glucosylceramide (c)
does not move beyond the early endosomal level during prolonged incubation in nocodazole-treated cells. (b) Phase-contrast image
corresponding to c and d. (e) After microtubuli disruption (nocodazole, 90 min), the cells were allowed to recover for 90 min in Hanks’
solution at 37˚C. Thereafter C6-NBD-glucosylceramide internalization proceeds normally, resulting in a labeling pattern resembling that
in a (control), but distinct from that in c. Thus inhibition of glucosylceramide trafficking to the central cell region is reversible. (f) After
internalization in the presence of nocodazole (compare c) and back-exchange (to remove residual plasma membrane NBD-lipid) the cells
were further incubated at 37˚C for 45 min. The plasma membrane staining indicates that recycling has occurred from peripheral early
endosomes. Bar, 10 m m.
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glycolipid can escape from this compartment and, unlike
N-Rh-PE and ricin, does not move further to the lysosomal
system but, rather, appears to be able to recycle to the
plasma membrane. Thus the large spherical vesicles that
contain C6-NBD-glucosylceramide after 15 min of uptake
are kinetically intermediate between early endosomes
(reached after 2 min of uptake of the glycolipid) and lyso-
somes (never reached by the glycolipid but for instance by
N-Rh-PE after 60 min of uptake). Therefore these vesicles
can be considered to be late endosomes.
The experimental results indicate that apart from recy-
cling via early endosomes, some of the lipid can be trans-
ported to the Golgi area, as occurs for Tf, while another
fraction reaches late endosomes, following the pathway
along which ricin is transferred. These events are schemat-
ically depicted in Fig. 6. It should be noted that beyond the
level of early endosomes, the pathways of Tf and the gly-
colipid are partly separated. At the late endosomal level the
receptor-mediated endocytic pathway, taken by a fraction
of the NBD-glycolipid, converges with the fluid-phase
endocytic pathway (Fig. 6), for which N-Rh-PE is used as
a membrane marker (Kok et al. 1990). In this context, note
that in contrast to the late endosomal level (Fig. 5 c,d), there
is no colocalization of C6-NBD-glucosylceramide and N-
Rh-PE at the early endosomal level (Fig. 5 a,b). This indi-
cates that a ‘cross-over’ occurs between these two endo-
cytic pathways at the level of the late endosome.
Apparently, in this late endosomal compartment the NBD-
glycolipid is sorted (e.g. from N-Rh-PE), allowing it to
recycle to the plasma membrane.
Involvement of the Golgi apparatus in recycling
After longer incubation times (15 min) part of the NBD-
glucosylceramide colocalizes with LR-Tf in the Golgi area
(see above). In order to establish whether the Golgi appa-
ratus is involved in recycling of the glycolipid, experiments
were carried out using monensin to disrupt the Golgi system
and to inhibit transport to the plasma membrane. The trans-
port to the plasma membrane of newly synthesizedC6-NBD-
glucosylceramide (or sphingomyelin) from the precursor
C6-NBD-ceramide in the Golgi apparatus, is ~50% reduced
in monensin-treated cells (Table 1). However, only a minor
effect of monensin is seen on the recycling of intactC6-
NBD-glucosylceramide after its initial uptake by endocy-
tosis. Furthermore, as shown in Fig. 7, the labeling pattern
observed after internalization of C6-NBD-glucosylceramide
is not changed when the cells are pretreated with BFA
(compare d vs. c), causing redistribution of the Golgi
system into the endoplasmic reticulum (Lippincott-
Schwartz et al. 1990), as demonstrated here (compare a vs.
b) by the distinct difference in the distribution of the Golgi
marker C6-NBD-ceramide. Also recycling of the glycolipid
was not affected, as judged by fluorescence microscopy (not
shown) and based on quantifying the recycled fraction
(Table 1). However, the transport of newly synthesized glu-
cosylceramide from the Golgi to the plasma membrane is
also unaffected by BFA treatment, in spite of the drastic
morphological changes (Fig. 7). 
In conclusion, monensin hardly affects overall recycling
while BFA, which is known to cause redistribution of the
cis to transGolgi compartments into the ER (Lippincott-
Schwartz et al. 1990), does not affect the labeling pattern
obtained after C6-NBD-glucosylceramide internalization,
including the Golgi-area labeling. Therefore the cistotrans
Golgi compartments do not seem to be involved in traf-
fi cking of endocytosed glucosylceramide. However, the
trans-Golgi network (TGN), an important sorting organelle
(Griffiths and Simons, 1986), is a possible candidate for
involvement in recycling of glucosylceramide. Monensin,
although affecting early transport steps of sphingolipids
fter synthesis (Table 1), may not affect cycling, occurring
directly through the TGN. Golgi area labeling would still
be observed in BFA-treated cells, when the TGN is not
affected by this treatment. Recently, BFA was reported to
affect organelles in the endocytic pathway as well (Wood
et al. 1991; Lippincott-Schwartz et al. 1991; Pelham, 1991).
Most notably, the drug appears to cause fusion of the TGN
with early endosomes in certain cell types. Possibly, this
henomenon may either not occur in BHK cells or does not
l ad to drastic morphological changes, given the similar
abeling patterns of glucosylceramide recycling organelles
in both BFA-treated and control cells (Fig. 7). Alternatively,
the G lgi area labeling may represent another type of endo-
soma  vesicle, in addition to the early and late endosomes
described above. In BHK cells, endosomal vesicles can be
found very close to the TGN (Griffiths and Simons, 1986).
Therefore, resolving this issue ultimately depends on the
availability of methods for electron microscopic visualiza-
tion of glucosylceramide in relation to established Golgi
markers, including specific TGN markers.
Table 1.Effect of monensin or BFA on C6-NBD-
glucosylceramide recycling







In the case of BFA treatment, BHK cells were preincubated with BFA
(2 µg/ml) in Hanks’ solution for 30 min at 37˚C. All subsequent
incub tions were also carried out in the presence of BFA. The cells were
labeled with 4 µM C6-NBD-glucosylceramide and allowed to internalize
the lipid for 30 min at 37˚C, whereafter a back-exchange procedure was
carried out to remove all residual plasma membrane NBD-lipid. In the
case of monensin-treatment, this was followed by a preincubation with
Hanks’ solution containing 10 µM monensin for 30 min at 2˚C.
Subsequently, recycling was allowed to proceed for 45 min by incubating
the cells at 37˚C, in either the presence (monensin or BFA) or the absence
(control) of drugs. Thereafter a final back-exchange procedure was
performed to analyse the C6-NBD-lipid present in this (recycling) fraction
and the residual intracellular fraction. From these data the relative
transport factor R was calculated, as described in Materials and methods. 
In a parallel experiment the effect of monensin or BFA on transport of
newly synthesized C6-NBD-glucosylceramide from the Golgi to the
plasma membrane was examined. In the case of BFA treatment, the cells
were preincubated with BFA (2 µg/ml) in Hanks’ solution for 30 min at
37˚C. The cells were labeled with 4 µM C6-NBD-ceramide at 2˚C for 30
min. I  the case of monensin-treatment this was followed by a
preincubation with Hanks’ solution containing 10 µM monensin for 30
min at 2˚C. Subsequently, the cells were incubated at 37˚C for 45 min,
followed by a back-exchange procedure to separate plasma membrane and




Recycling does not depend on the presence of intact micro-
tubuli or actin filaments. When cells were treated with noco-
dazole or cytochalasin D to disrupt these respective
ytoskeletal elements, recycling was not inhibited (Figs 3
and 8).
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Fig. 4.Double-labeling patterns after internalization of C6-NBD-glucosylceramide together with either LR-ricin or LR-Tf. (a-j) BHK
cells were labeled with C6-NBD-glucosylceramide (a,c,f,h) and LR-ricin (b,d,g,i), as described in Materials and methods. Subsequently
the cells were incubated at 37˚C for 2 min (a,b,e), 15 min (c,d), 30 min (f,g) and 60 min (h,i,j). Thereafter a back-exchange procedure and
a 0.1 M lactose wash were performed. Cells shown in a,b,e were fixed, as described in Materials and methods. Up to 30 min (f,g)
colocalization is observed, but after 60 min (h,i,j) very large spherical vesicles become labeled by ricin, but do not contain
glucosylceramide. (k-p) BHK cells were labeled with C6-NBD-glucosylceramide (l,n) and LR-Tf (m,o), as described in Materials and
methods. Subsequently the cells were incubated at 37˚C for 15 min, followed by a back-exchange procedure and fixing of the cells as
described in Materials and methods. Phase-contrast image (k) corresponds to (l) and (m), whereas (p) corresponds to (n) and (o). Arrows
indicate large spherical vesicles (late endosomes) which contain C6-NBD-glucosylceramide, but not LR-Tf. Thus glucosylceramide
colocalizes with ricin (c,d), but not with transferrin (k-p) in late endosomes after 15 min at 37˚C. Bars, 10 m m.
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Fig. 5.Double-labeling patterns after
internalization of C6-NBD-glucosylceramide and
N-Rh-PE. BHK cells were labeled with C6-NBD-
glucosylceramide (a,c,e) and N-Rh-PE (b,d,f), as
descibed in Materials and methods. Subsequently
the cells were incubated at 37˚C for 2 min (a,b) and
15 min (c,d and e,f,g), followed by a back-
exchange procedure. Cells shown in e,f,g were then
further incubated at 37˚C for 5 min, in order to
chase the C6-NBD-glucosylceramide out of the
large spherical vesicles, indicated by arrows. In all
samples the cells were fixed as described in
Materials and methods. Bars, 10 m m.
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To characterize recycling further, several parameters
were examinated to determine whether or not recycling was
affected. Ammonium chloride (20 mM), and both low (pH
5.5) and high (pH 9.5) extracellularpH did not influence
recycling as judged by microscopy (not shown). However,
when the intracellular pH was lowered to 5.5 using
nigericin, recycling was severely inhibited (Fig. 8), while
the intracellular distribution of fluorescence changed.
Whereas in control cells the NBD-glycolipid is found in the
cell center, in acidified cells the lipid analog is seen in irreg-
ularly shaped vesicles, scattered all over the cell (Fig. 8).
Thus it appears that the extent to which the intracellular pH
is lowered is of importance for the inhibitory effect on recy-
cling, since simply lowering the extracellular pH is not suf-
fi cient. The latter method has been used to study pH-depen-
dent internalization in BHK cells (Davoust et al. 1987). It
was shown that by lowering the extracellular pH to 5.7 the
intracellular pH dropped to 6.2. Apparently the threshold
intracellular pH for inhibition of recycling is between 5.5
and 6.2. The pH-dependence suggests that recycling may
be accomplished by vesicular transport, in spite of the lack
of microscopic visualization of carrier vesicles. It would be
expected that the use of metabolic inhibitors would also
affect recycling to a major extent, since such treatments
have been reported to inhibit vesicular transport completely
during internalization (Sleight and Pagano, 1984). In the
presence of such inhibitors (5 mM sodium azide/50 mM 2-
deoxyglucose) recycling was indeed inhibited, as judged by
microscopy (Fig. 8). In this case intracellular C6-NBD-glu-
cosylceramide was still present in the cell center, as
observed in control cells. As shown in Table 2, none of the
inhibitors of recycling blocked the process completely.
However, the extent of inhibition found in these experi-
ments may be an underestimation, since in control cells part
of the recycled C6-NBD-glucosylceramide was reinternal-
ized in the time-span of 45 min, whereas in acidified cells
(re)internalization is effectively inhibited (Cosson et al.
1989; and our own unpublished observations). Furthermore,
in contrast to acidification of the cytosol, which is a rela-
tiv ly fast process, the lag time before metabolic inhibitors
exert their effect may be longer. This could explain the
slightly less efficient inhibition of recycling under these
conditions.
In conclusion, the present work demonstrates that recy-
cling of a fluorescent analog of glucosylceramide can occur
at t e level of early endosomes, very similar to reports from
 variety of proteins, such as Tf and its receptor. Also, the
late endosomal compartment appears to play a role in glu-
cosylceramide recycling. Involvement of early Golgi com-
partments seems to be very minor, but in all likelihood the
TGN does play a role in recycling of the glycolipid. Defin-
ing this role more accurately will require further work.
Whether the latter pathways reflect an ‘overflow-salvage’
mechanism, as has been suggested (see Hoekstra et al. 1989,
and references therein) for Tf recycling via early endosomes
andthe Golgi complex also remains to be established.
Finally, the trafficking of glucosylceramide seems to
resemble to a certain extent that of sphingomyelin in cul-
tured fibroblasts (Koval and Pagano, 1989), thus indicating
Fig. 6.A schematic view of the internalization and recycling
pathways of C6-NBD glucosylceramide in BHK cells.
Glucosylceramide enters the cell along the pathway of receptor-
mediated endocytosis, together with transferrin and ricin, and
reaches the early endosomes (1). From this sorting compartment
the glycolipid can - like transferrin - directly recycle to the plasma
membrane. Apart from recycling, the glycolipid moves to late
endosomes (2) and is thus partly sorted from transferrin, which is
only transported to the Golgi area (G.A.) when moving further
into the cell (4). Unlike transferrin, the other endocytic marker
ricin does move to the late endosomes, together with
glucosylceramide. In this late endosomal compartment a “cross-
over” occurs between the receptor-mediated and fluid-phase
endocytic pathways, since glucosylceramide and N-Rh-PE
colocalize in this compartment (2) and not in early endosomes (1).
Apparently, glucosylceramide can escape from this late
endosomal compartment and thus avoid degradation in the
lysosomal compartment (3), to which both N-Rh-PE and ricin are
directed. In this way the glycolipid can recycle to the plasma
membrane, either directly or via the Golgi area. However, the
Golgi apparatus per se is not involved in this recycling pathway.
During its intracellular movement in the endocytic pathway, a
small fraction of the glucosylceramide is degraded to ceramide,
which moves to the Golgi apparatus, where it can be reutilized for
the synthesis of sphingolipids. This latter pathway is not depicted
here. N, nucleus.
Table 2.Effect of metabolic inhibitors or acidification of






BHK cells were labeled with 4 µM C6-NBD-glucosylceramide and
allowed to internalize the lipid for 30 min at 37˚C, after which a back-
exchange procedure was carried out to remove all residual plasma
membrane NBD-lipid. Subsequently the cells were preincubated with
Hanks’ solution (control) or the same solution containing 5 mM sodium
azide/50 mM 2-deoxyglucose (metabolic inhibitors), or a nigericin (5
µM)-containing isotonic KCl buffer solution (acidification cytosol) for 30
min at 2˚C, followed by incubation at 37˚C for 45 min. Thereafter another
back-exchange procedure was performed to analyse the NBD-lipid present
in this (recycling) fraction and the residual intracellular fraction, as
described in Materials and methods. Recycling is expressed as the relative
transport factor R, as described in Materials and methods. Data are the
means of triplicate measurements with standard deviations <10%. Note
that Fig. 8 shows corresponding images of the NBD-glucosylceramide
fluorescence distribution.
1150 J. W. Kok and others
Fig. 7. Effect of BFA on the Golgi apparatus and the endocytic trafficking of C6-NBD- lucosylceramide. (a) BHK cells were labeled with
4 m M C6-NBD-ceramide for 30 min at 37˚C. (b) Cells were labeled as in a, followed by another 30 min incubation at 37˚C in the presence
of BFA (2 m g/ml) and a back-exchange. Note that BFA treatment causes spreading of C6-NBD-lipids from the Golgi all over the cell.
(d) BHK cells were preincubated for 30 min at 37˚C with BFA. Thereafter the cells were labeled with 4 m M C6-NBD-glucosylceramide
(+ BFA) at 2˚C, followed by a 30 min incubation at 37˚C in the presence of BFA. Finally a back-exchange procedure was performed
(f, corresponding phase-contrast image). (c) Control cells were treated as in d, but Hanks’ buffer without BFA was used for all
incubations (e, corresponding phase-contrast image). Note that BFA treatment does not change the NBD-glucosylceramide labeling
pattern, under conditions where Golgi-localized NBD-lipids are spread all over the cell (b). Further note in Table 1 that BFA does not
affect recycling of glucosylceramide, starting from the situation as in d. Bars, 10 m m.
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that sphingolipids may follow similar routes in fibroblasts.
However, the routing of (glyco)sphingolipids cannot be
generalized for all cell types, since we have shown else-
where that in the human (epithelial) carcinoma HT29 cell
line, glucosylceramide is directed to the Golgi apparatus
during internalization (Kok et al. 1991). Thus glucosyl-
ceramide follows different pathways in HT29 cells versus
fi broblasts. These distinct differences in different cell types
may provide interesting possibilities for examining the
underlying mechanisms that direct glycolipid trafficking in
cells.
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